ArticleBMC cancer2019

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.

Wilson Eduardo Furlan Matos Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.